{"entity":{"id":"nct05503797","kind":"trial","name":"A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations","aka":[],"tldr":"A phase 2 trial of Plixorafenib in advanced solid tumours, run by Fore Biotherapeutics, now recruiting.","summary":"A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations is a phase 2 interventional study registered as NCT05503797 by Fore Biotherapeutics, with 254 participants planned, started 2023-02-21 and due to reach its primary completion in 2027-12-31. Interventions recorded: Plixorafenib.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT05503797","url":"https://clinicaltrials.gov/study/NCT05503797"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":["braf"],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05503797","phase":"2","setting":"A Phase 2 Master Protocol to Assess the Efficacy and Safety of FORE8394, an Inhibitor of BRAF Class 1 and Class 2 Alterations, in Participants With Cancer Harboring BRAF Alterations","sponsor":"Fore Biotherapeutics","participation":[{"nct":"NCT05503797","source":"https://clinicaltrials.gov/study/NCT05503797","fetchedAt":"2026-10-07T16:53:44.279Z","studySha256":"d06e0fc8fc9e45b573d86dfe8503f8141b1f0c9fbc8f8bbedb26164f79e3a29e","overallStatus":"RECRUITING","lastUpdatePosted":"2026-07-27","leadSponsor":"Fore Biotherapeutics","collaboratorCount":0,"minimumAge":"8 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":254,"enrolmentType":"ESTIMATED","siteCount":70,"recruitingSiteCount":67,"countries":["Australia","Canada","France","Germany","Italy","Netherlands","Norway","South Korea","Spain","Sweden","United Kingdom","United States"]}],"started":"2023-02-21","startedType":"actual","enrolled":254,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05503797/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"target":[{"id":"braf","kind":"target","name":"BRAF","route":"/targets/braf/"}],"institution":[{"id":"ucsf","kind":"institution","name":"UCSF Helen Diller Family Comprehensive Cancer Center","route":"/institutions/ucsf/"}]}}